Paliperidone is an atypical antipsychotic that acts as an antagonist at dopamine D2 and serotonin 5-HT2A receptors, with additional antagonistic activity at α1, α2 adrenergic, and H1 histamine receptors. It is widely used in research models of schizophrenia and psychosis for both in vitro receptor binding studies and in vivo behavioral experiments.